Today the eczema community is one step closer to having a new treatment option. The U.S. Food and Drug Administration (FDA) has approved Opzelura (ruxolitinib) cream, from manufacturer Incyte, for the short-term and non-continuous chronic…
Published On: Jun 1, 2021
Last Updated On: Jun 1, 2021
In this animated video for kids, Maya talks to her friends Corey and Tia about her experience being in a clinical trial for a new eczema treatment.